Vanguard Group
ASXC

Vanguard Group’s Asensus Surgical, Inc. ASXC Stock Holding History

Quarter Market Value Status Shares Shares
Change %
Trade Value Portfolio Weight Portfolio Position
2024
Q3
Sell
-11,588,282
Closed -$3.86M 4414
2024
Q2
$3.86M Hold
11,588,282
﹤0.01% 3361
2024
Q1
$2.67M Buy
11,588,282
+1,122
+0% +$258 ﹤0.01% 3502
2023
Q4
$3.7M Buy
11,587,160
+193,703
+2% +$61.8K ﹤0.01% 3396
2023
Q3
$3.08M Hold
11,393,457
﹤0.01% 3444
2023
Q2
$5.75M Sell
11,393,457
-43,403
-0.4% -$21.9K ﹤0.01% 3239
2023
Q1
$7.53M Hold
11,436,860
﹤0.01% 3101
2022
Q4
$3.97M Buy
11,436,860
+5,068
+0% +$1.76K ﹤0.01% 3411
2022
Q3
$5.13M Buy
11,431,792
+575,904
+5% +$258K ﹤0.01% 3312
2022
Q2
$4.32M Buy
10,855,888
+715,839
+7% +$285K ﹤0.01% 3451
2022
Q1
$6.36M Sell
10,140,049
-1,027,932
-9% -$644K ﹤0.01% 3401
2021
Q4
$12.4M Buy
11,167,981
+77,444
+0.7% +$86K ﹤0.01% 3104
2021
Q3
$20.5M Sell
11,090,537
-297,069
-3% -$550K ﹤0.01% 2852
2021
Q2
$36.1M Buy
11,387,606
+5,254,805
+86% +$16.7M ﹤0.01% 2540
2021
Q1
$19.9M Buy
6,132,801
+3,973,807
+184% +$12.9M ﹤0.01% 2787
2020
Q4
$1.35M Buy
2,158,994
+333,290
+18% +$208K ﹤0.01% 3755
2020
Q3
$634K Buy
1,825,704
+1,176,230
+181% +$408K ﹤0.01% 3766
2020
Q2
$351K Sell
649,474
-61,131
-9% -$33K ﹤0.01% 3845
2020
Q1
$250K Sell
710,605
-32,715
-4% -$11.5K ﹤0.01% 3823
2019
Q4
$1.09M Sell
743,320
-9,149,682
-92% -$13.5M ﹤0.01% 3619
2019
Q3
$6.13M Buy
9,893,002
+661,596
+7% +$410K ﹤0.01% 3059
2019
Q2
$12.6M Buy
9,231,406
+991,120
+12% +$1.35M ﹤0.01% 2728
2019
Q1
$19.6M Buy
8,240,286
+507,042
+7% +$1.21M ﹤0.01% 2514
2018
Q4
$17.5M Sell
7,733,244
-721,812
-9% -$1.63M ﹤0.01% 2507
2018
Q3
$49M Buy
8,455,056
+1,003,091
+13% +$5.82M ﹤0.01% 2153
2018
Q2
$32.5M Buy
7,451,965
+1,828,161
+33% +$7.97M ﹤0.01% 2347
2018
Q1
$9.56M Buy
5,623,804
+392,525
+8% +$667K ﹤0.01% 2845
2017
Q4
$10.1M Buy
5,231,279
+2,074,428
+66% +$4M ﹤0.01% 2812
2017
Q3
$4.51M Buy
3,156,851
+999,617
+46% +$1.43M ﹤0.01% 3158
2017
Q2
$1.53M Sell
2,157,234
-265,779
-11% -$189K ﹤0.01% 3461
2017
Q1
$2.93M Buy
2,423,013
+47,683
+2% +$57.7K ﹤0.01% 3260
2016
Q4
$3.09M Buy
2,375,330
+160,925
+7% +$209K ﹤0.01% 3217
2016
Q3
$3.74M Buy
2,214,405
+198,713
+10% +$336K ﹤0.01% 3142
2016
Q2
$2.46M Buy
2,015,692
+207,773
+11% +$253K ﹤0.01% 3299
2016
Q1
$7.68M Buy
1,807,919
+331,010
+22% +$1.41M ﹤0.01% 2749
2015
Q4
$3.66M Buy
1,476,909
+83,922
+6% +$208K ﹤0.01% 3124
2015
Q3
$3.15M Buy
1,392,987
+210,199
+18% +$475K ﹤0.01% 3175
2015
Q2
$3.55M Buy
1,182,788
+481,017
+69% +$1.44M ﹤0.01% 3172
2015
Q1
$2.06M Buy
701,771
+145,765
+26% +$427K ﹤0.01% 3401
2014
Q4
$1.62M Buy
556,006
+69,135
+14% +$201K ﹤0.01% 3360
2014
Q3
$2.12M Buy
486,871
+20,500
+4% +$89.4K ﹤0.01% 3236
2014
Q2
$2.35M Buy
+466,371
New +$2.35M ﹤0.01% 3192